Innovative Medicine Initiatives

The Innovative Medicines Initiative (IMI) is a European Union funding organization that supports collaborative pharmaceutical research through grants for drug development, diagnostics, and clinical trials. As Europe's largest public-private partnership in life sciences, IMI brings together industry, academia, and patient organizations to accelerate medical innovation. Eligibility criteria and funding amounts vary depending on the specific program and call for proposals.

IMI provides funding for collaborative research projects in the field of pharmaceuticals, including research on new drugs, diagnostics, and clinical trials. Eligibility criteria and funding amounts can vary by program.